Search for: "AJINOMOTO V ITC"
Results 1 - 20
of 20
Sorted by Relevance
|
Sort by Date
20 Nov 2009, 2:44 pm
On December 10, 2009, the Federal Circuit is scheduled to hear oral argument in Ajinomoto Co., Inc. v. [read post]
8 Mar 2010, 2:44 pm
Further to our November 20, 2009 post, on March 8, 2010, the Federal Circuit issued its decision in Ajinomoto Co., Inc. v. [read post]
13 Aug 2019, 9:59 pm
Ajinomoto petitioned the International Trade Commission (ITC) under Section 337 (19 U.S.C. [read post]
10 Mar 2010, 7:32 am
Ajinomoto Co., Inc. v. [read post]
9 Mar 2010, 4:18 pm
Ajinomoto v. [read post]
15 Mar 2010, 7:56 pm
By Suresh Pillai -- Last week, the Federal Circuit affirmed a determination by the International Trade Commission ("ITC") that: (1) the asserted claims of U.S. [read post]
11 Mar 2010, 12:28 pm
Ajinomoto v. [read post]
30 May 2020, 8:32 am
Holman: Ajinomoto v. [read post]
8 Aug 2019, 10:39 am
ITC; CJ CheilJedang Corp. v. [read post]
25 Aug 2018, 2:23 pm
Ajinomoto Co., Inc. v. [read post]
20 Aug 2019, 2:05 am
ITC and Eli Lilly and Co. v. [read post]
27 Oct 2010, 8:30 am
Patent Nos. 5,827,698 (the “ ‘698 patent”) and 6,040,160 (the “ ‘160 patent”).[8] In April of 2006, Ajinomoto filed a complaint with the International Trade Commission (“ITC”) alleging that the importation of various lysine feed products was a violation of section 337 of the Tariff Act of 1930 as amended, 19 U.S.C. [read post]
10 Mar 2010, 5:22 am
(Patent Docs) US: CAFC affirms ITC’s final determination of invalidity of two patents for violating best mode requirement and unenforceability of one patent due to inequitable conduct: Ajinomoto Co., Inc v ITC (ITC 337 Law Blog) Products Aldara (Imiquimod) - FDA rules against forfeiture for generic Aldara cream (FDA Law Blog) Flomax (Tamsulosin) - US: Has Ranbaxy intentionally forfeited 180-day exclusivity for monetary benefit? [read post]
10 Mar 2010, 5:22 am
(Patent Docs) US: CAFC affirms ITC’s final determination of invalidity of two patents for violating best mode requirement and unenforceability of one patent due to inequitable conduct: Ajinomoto Co., Inc v ITC (ITC 337 Law Blog) Products Aldara (Imiquimod) - FDA rules against forfeiture for generic Aldara cream (FDA Law Blog) Flomax (Tamsulosin) - US: Has Ranbaxy intentionally forfeited 180-day exclusivity for monetary benefit? [read post]
4 Jun 2011, 4:13 pm
Ajinomoto, 597 F.3d at 1272; OSRAM GmbH v. [read post]
25 Nov 2009, 12:00 pm
US: Federal Circuit to hear oral argument in Ajinomoto v ITC 10 December (ITC Law Blog) US: Athena Diagnostics files suits against Ambry Genetics over alleged infringement of patents covering diagnostic technologies (Patent Docs) Products Dovonex (Calcipotriol) – UK: EWCA (Civ): Follow the instruction or lose the case - Sandoz's attempts at having finding of lack of anticipation overturned fails, appeal dismissed: Leo v Sandoz (IPKat)… [read post]
18 Mar 2010, 2:30 am
Hinchey introduces the FDA Improvement Act of 2010; the Bill would unravel User Fee Legislation, among other changes (FDA Law Blog) US: CAFC affirms invalidity of Lysine-producing bacterium patents for lack of best mode: Ajinomoto v. [read post]
18 Apr 2008, 2:00 am
– ownership of IP: (Dilanchian), Consultant or contractor IP: (Dilanchian), IP and general business law issues: Website terms of use reduce risk: (Dilanchian), Plant breeder’s rights actions in the Federal Court will now be regarded as IP cases for the purpose of docket allocation: (IPwar’s), Ajinomoto v NutraSweet – inventive step and costs: (IPRoo), Australian Federation Against Copyright Theft 2020 submission:… [read post]
28 Mar 2008, 6:00 am
: (Afro-IP),If education and pricing policy fail, says Adobe in Nigeria, we can still sue: (Afro-IP),South African arm of Chrysler objects to advertisement by Indian vehicle maker Mahindra and Mahindra that uses the term "jeep": (Afro-IP), (Spicy IP),Kenya’s call for anti-counterfeit legislation… amongst other changes: (Afro-IP),Kenya: Shared computer use raises privacy, confidentiality issues: (Afro-IP)AustraliaChanges to grace period for trade mark renewal:… [read post]
16 May 2008, 8:03 am
: (GenericsWeb), Europe: New EBA referral T 1319/04 regarding patentability of known medicament for new treatment of same illness: (IPKat), Europe: Patentability of biotechnology in Europe: (IAM), Europe: New EPO Enlarged Board case referrals: T1319/04 Dosage Regimen, T1242/06 Essential Biological Process: (Hal Wegner), Thailand: Compulsory licensing: Affordable health for Thailand thanks to Matrix Labs: (Spicy IP), Thailand: European Parliament set to reprimand Mandelson for… [read post]
